Related Experiment Video

Updated: Feb 8, 2026

Isolated Hepatic Perfusion as a Treatment for Liver Metastases of Uveal Melanoma
09:52

Isolated Hepatic Perfusion as a Treatment for Liver Metastases of Uveal Melanoma

Published on: January 25, 2015

13.9K

Melanoma treatment in review

Beatriz Domingues1,2,3, José Manuel Lopes1,2,4,5, Paula Soares1,2,5

  • 1Institute of Molecular Pathology and Immunology, University of Porto (IPATIMUP), Porto, Portugal.

Immunotargets and Therapy
|June 21, 2018
PubMed

Insights

This review surveys melanoma treatments, including immunotherapy and targeted therapy, and discusses molecular mechanisms driving skin cancer. Understanding these targets is crucial for developing more effective melanoma therapies.

Area of Science:

  • Oncology
  • Dermatology
  • Cancer Research

Background:

  • Melanoma is an aggressive skin cancer with diverse treatment options.
  • Therapeutic resistance mechanisms limit the effectiveness of current treatments.
  • Understanding melanoma pathogenesis is key to identifying new therapeutic targets.

Purpose of the Study:

  • To review approved and emerging melanoma therapies.
  • To explore molecular mechanisms underlying melanoma development.
  • To provide insights into novel therapeutic strategies for melanoma.

Main Methods:

  • Literature review of approved and investigational melanoma treatments.
  • Analysis of research on molecular factors in melanomagenesis.
  • Survey of genetic profiling studies in melanoma.

Main Results:

  • Current melanoma therapies include surgery, chemotherapy, immunotherapy, and targeted therapy.
  • Resistance mechanisms pose a significant challenge in melanoma treatment.
  • New therapeutic targets are being identified through molecular and genetic studies.

Conclusions:

  • Combination therapies and novel agents show promise for melanoma treatment.
  • Further research into melanomagenesis can lead to improved therapeutic strategies.
  • Personalized medicine approaches are essential for effective melanoma management.
Keywords:
cancermelanomatargetstherapy

More Related Videos

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis07:41

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

2.9K
A Melanoma Patient-Derived Xenograft Model07:07

A Melanoma Patient-Derived Xenograft Model

Published on: May 20, 2019

13.2K

Related Concept Videos

Review and Preview01:10

Review and Preview

In statistics, several tools are used to interpret the data. Measures of central tendency represent the characteristics of the data, such as mean, median, and mode. Additionally, measures of variance like standard deviation and range are used to find the spread of data from the mean. Relative standing measures the distance between data locations. Commonly used measures of relative standings are percentile, z score, and quartiles.
Percentiles are a type of fractile that partition data into...
8.4K
Review and Preview01:13

Review and Preview

Data are individual items of information obtained from a population or sample. Data may be classified as qualitative (categorical), quantitative continuous, or quantitative discrete. Because it is not practical to measure the entire population in a study, researchers use samples to represent the population. A random sample is a representative group from the population chosen by using a method that gives each individual in the population an equal chance of being included in the sample. Random...
11.5K
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
1.0K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.2K
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
968